Title |
Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients
|
---|---|
Published in |
AIDS Research and Therapy, August 2010
|
DOI | 10.1186/1742-6405-7-32 |
Pubmed ID | |
Authors |
Verena Gounden, Chantal van Niekerk, Tracy Snyman, Jaya A George |
Abstract |
The 516G > T polymorphism in exon 4 of the CYP2B6 gene has been associated with increased plasma Efavirenz (EFV) concentrations. EFV concentrations greater than the recommended therapeutic range have been associated with the increased likelihood of developing adverse CNS effects. The aims of this study were to a) determine the presence of the 516G > T and other CYP2B6 exon 4 polymorphisms in a South African group of HIV-infected individuals b) investigate the relationship between the EFV plasma concentrations, the CYP2B6 516G > T polymorphism and the occurrence of CNS related side effects in this group of patients and c) develop and validate a rapid method for determination of EFV in plasma. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
South Africa | 2 | 2% |
Peru | 1 | 1% |
Nigeria | 1 | 1% |
Unknown | 87 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 19% |
Student > Master | 17 | 19% |
Student > Bachelor | 10 | 11% |
Student > Postgraduate | 9 | 10% |
Researcher | 8 | 9% |
Other | 14 | 15% |
Unknown | 16 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 31% |
Agricultural and Biological Sciences | 14 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 15% |
Biochemistry, Genetics and Molecular Biology | 7 | 8% |
Nursing and Health Professions | 2 | 2% |
Other | 9 | 10% |
Unknown | 17 | 19% |